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<AB>Abstract 
Background: Transition to enteral feeding is difficult for very low birth weight (VLBW; 
≤1500 g) infants, and optimal nutrition is important for clinical outcomes. Method: Data on 
feeding practices and short-term clinical outcomes (growth, necrotizing enterocolitis [NEC], 
mortality) in VLBW infants were collected from 13 neonatal intensive care units (NICUs) in 
5 continents (n = 2947). Specifically, 5 NICUs in Guangdong province in China (GD), 
mainly using formula feeding and slow feeding advancement (n = 1366), were compared with 
the remaining NICUs (non-GD, n = 1581, Oceania, Europe, United States, Taiwan, Africa) 
using mainly human milk with faster advancement rates. Results: Across NICUs, large 
differences were observed for time to reach full enteral feeding (TFF; 8–33 days), weight 
gain (5.0–14.6 g/kg/d), ∆z-scores (−0.54 to −1.64), incidence of NEC (1%–13%), and 
mortality (1%–18%). Adjusted for gestational age, GD units had longer TFF (26 vs 11 days), 
lower weight gain (8.7 vs 10.9 g/kg/d), and more days on antibiotics (17 vs 11 days; all P < 
.001) than non-GD units, but NEC incidence and mortality were similar. Conclusion: Feeding 
practices for VLBW infants vary markedly around the world. The practice with much use of 
formula and long TFF in South China was associated with more use of antibiotics and slower 
weight gain, but apparently not with more NEC or higher mortality. Both infant- and 
hospital-related factors influence feeding practices for preterm infants. Multicenter, 
randomized controlled trials are required to identify the optimal feeding strategy during the 
first weeks of life. (JPEN J Parenter Enteral Nutr. XXXX;xx:xx-xx)</AB> 
 
<KW>Keywords 
XXX</KW> 
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Clinical Relevancy Statement 
Early transition to enteral nutrition, especially using mother’s own milk, is believed to be 
important for growth, health, and development of preterm infants. Many factors may interact 
to determine the feeding practices at neonatal intensive care units (NICUs) around the world, 
including clinical traditions, available milk diets, and structural limitations at individual 
hospitals. Our cohort study shows that a relatively long time to reach full enteral feeding in 5 
NICUs in South China with predominantly infant formula feeding was associated with more 
frequent use of antibiotics and less weight gain during the first 4 weeks of age, but apparently 
not with increased risk for necrotizing enterocolitis or death, relative to 8 other NICUs 
around the world, using faster feeding advancement rates with predominantly human milk. It 
may be important to vary nutrition strategies (eg, feeding advancement rate, criteria for 
withhold of feeding) according to different NICU settings (eg, availability of human milk). 
 
<H1>Introduction</H1> 
Preterm birth is a major cause of morbidity and mortality, especially for very low birth 
weight (VLBW; ≤1500 g) infants.1 Survival of VLBW infants has increased in recent years 
because of novel perinatal interventions, but clear evidence for the optimal postnatal nutrition 
strategy is lacking. Optimal nutrition status may be critical to prevent adverse in-hospital 
outcome and support long-term development (eg, neurodevelopment).2-5 Early and fast 
increase in enteral feeding is preferred, relative to prolonged use of parenteral nutrition (PN), 
to reduce sepsis, liver problems, and persistent gut immaturity.
6,7
 Cochrane reviews show that 
early introduction and progressive advancement of enteral feeding are not associated with 
more necrotizing enterocolitis (NEC) than slow feeding,
8-11
 but the evidence remains 
inconsistent.
12-14
 Many feeding guidelines recommend early and progressive enteral 
feeding,
15,16
 but it is challenging to adhere to such guidelines due to fear of NEC and 
nonspecific signs of feeding intolerance, especially for very immature infants
17 in hospitals 
with limited access to human milk. 
There is a consensus that own mother’s milk (MM) is the best diet during the first weeks after 
birth for high-risk preterm infants.
18,19
 The evidence in favor of human donor milk (DM) is 
more variable,
20
 whereas infant formula (IF) is inferior to MM with regard to clinical 
outcomes (eg, NEC, sepsis, mortality).21 Therefore, in neonatal intensive care units (NICUs) 
with low availability of human milk, the clinical concern for NEC may be greater and the 
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time to reach full enteral feedings (TFF) longer. In addition, limited access to nutrition, 
medical, and surgical support in NICUs in low- and middle-income countries may influence 
the chosen nutrition practices.
22
 
In this observational cohort study, we explored the nutrition practices and short-term clinical 
outcomes in 13 NICUs in 9 countries from 5 continents. Before this study, we informally 
observed that NICUs in the Guangdong province in South China (GD) had limited access to 
human milk and a slow feeding advancement, relative to other NICUs (non-GD) in our 
research network focusing on preterm nutrition. Thus, we specifically aimed to investigate 
whether the short-term clinical outcomes (growth, NEC incidence, mortality) differed 
between GD and non-GD NICUs. In addition, the GD region has a rapidly growing 
population and economy, with new hospital infrastructure, making it important to study how 
hospital-related factors may influence feeding practices and clinical outcomes. Data included 
time to full enteral feeding, diet type, duration of PN, and prebiotics and antibiotics use, 
together with growth, NEC, and mortality rates. 
 
<H1>Methods</H1> 
<H2>Study Design and Subjects</H2> 
The NEOMUNE-NeoNutriNet was a combined retrospective and prospective cohort study to 
describe nutrition practices and short-term clinical outcomes in VLBW infants. Inclusion 
criteria were infants with a body weight ≤1500 g and admitted to the participating NICUs 
within 24 hours after birth. Exclusion criteria included major congenital abnormalities, 
metabolic disease, and transfer to another hospital within 24 hours of birth. Thirteen hospitals 
participated in the study across Europe (3), Oceania (2), North America (1), Africa (1), and 
Asia (6). Selection of the participating units was based on personal contact with the lead 
investigators and participation in the NEOMUNE research network 
(http://www.neomune.ku.dk). 
 
<H2>Ethics</H2> 
The study was approved by the ethical committee of VU University Medical Center, 
Amsterdam, the Netherlands, and at individual hospitals when required. Parental informed 
consents were obtained in 1 hospital but were not necessary in others because collected data 
were anonymous and were routinely collected as part of clinical care. A contract research 
organization was responsible for regulatory and safety aspects of the database (Academic 
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Medical Center, Amsterdam, the Netherlands). 
 
<H2>Data Collection and Outcomes</H2> 
Entry into the web-based database started on September 15, 2013. For each unit the aim was 
to include at least 100 infants, born consecutively between January 1, 2011, and September 
15, 2014. Case report forms were used to collect information from medical and nursing 
records including infant demographics (gestational age [GA] and anthropometrics at birth, 
gender, delivery mode, antenatal corticosteroids), nutrition regimens (timing and type of 
enteral nutrition [EN] and PN, time to reach enteral feeding volumes of 120 [TFF120] or 150 
mL/kg/d [TFF150]), use of probiotics, and clinical outcomes (use of antibiotics, respiratory 
support, NEC incidence, defined as Bell stage II23), all-cause mortality, and weekly 
anthropometric data (eg, weight, length, head circumference). Small for gestational age 
(SGA) was defined as <10th percentile for weight at birth. The Newcastle unit did not record 
TFF120, and the Taiwan site did not collect data on infants who died. All data were collected 
until postconceptional age (PCA) 37 weeks, or less if infants were transferred to a step-down 
unit, discharged to home, discharged on parental request before reaching discharge criteria, or 
died. Complying with the recommendations on reporting growth-related outcomes in preterm 
infants,
24
 the growth was reported from birth with the Fenton 2013 growth chart
25
 as the 
growth reference. Weight was reported in z-scores, and ∆z-scores from birth to 28 days were 
used to assess changes in weight over time. The exponential method by Patel et al
26
 was used 
to calculate weight gain velocity. 
 
<H2>Statistical Analysis</H2> 
All statistical analyses were performed using the R software package (version 3.2.2). Data 
were summarized using means and SDs, medians and interquartile ranges (IQRs), numbers 
and percentages, as appropriate. Median and IQR were used in cases of right-censored time-
to-event data (eg, TFF). Comparisons of demographic characteristics listed in Table 1 
between GD and non-GD NICUs were based on analysis of variance for continuous 
outcomes (eg, body weight [BW]) and logistic regression models for binary outcomes (eg, 
SGA). In Table 2, all outcome comparisons between GD and non-GD units were performed 
with or without adjustments for GA. Time-to-event data were compared using Cox 
proportional hazard models, and other continuous outcomes (eg, weight) were compared 
based on analysis of variance. Binary outcomes (eg, mortality) were compared using logistic 
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regression models. Adjustment for GA was done using the groups <28, 28, 29, 30, 31, 32, 
and >32 weeks because of the nonlinear relation between GA and clinical outcomes. 
Nonparametric Kruskal-Wallis test was used when normal distribution could not be achieved. 
A P-value <.001 was considered significant, whereas .01 < P < .001 as a tendency to an 
effect. We used this very restrictive approach to statistical differences, considering the large 
number of comparisons performed, and the possible inflation of significancy by cluster 
effects. 
 
<H1>Results</H1> 
A total of 2947 infants (GD, n = 1366; non-GD, n = 1581) were collected from the 13 NICUs 
that each included >100 consecutively born VLBW infants (except 1 unit with n = 93; Table 
1). Mean GA and BW ranged widely among NICUs and specifically, infants in the 5 GD 
units had higher GA and BWs (30.3 ± 2.1 weeks, 1250 ± 182 g) than the infants from non-
GD units (29.0 ± 2.6 weeks, 1086 ± 262 g, both P < .001; Table 1). Likewise, birth length 
and head circumference were higher in GD infants (both P < .001; Table 1). z-Scores of BW, 
birth length, and head circumference did not differ (Table 1). The overall mean values for 
proportion of SGA infants (~20%), singletons (~70%), and caesarean deliveries (~60%) were 
similar between GD and non-GD units (Table 1), whereas the proportion of males was higher 
in the GD units (56% vs 48% in non-GD units; P < .001). Use of antenatal steroids was less 
prevalent in GD vs non-GD units (49% vs 83%), and likewise there was less use of probiotics 
(21% vs 35%; all P < .001; Table 1). 
As predicted before the study, most infants in the 5 GD units were formula-fed during the 
first 4weeks (Figure 1). The proportion of infants receiving exclusively IF during the first 4 
weeks was 74% in GD vs 5% in non-GD units (P < .001). Provision of MM varied widely 
among NICUs, and DM was available in only 3 units (Amsterdam, Copenhagen, and Perth). 
Nine units used human milk fortifier for some infants (14% in GD and 67% in non-GD 
units), being initiated from 10 to 24 days after birth (Table 1). The GD units reported more 
early discharge on parental request, relative to non-GD units (22% vs 1%; P < .001). 
Among the clinical outcomes (Table 2), mortality (1%–18% across all NICUs) was similar 
between GD and non-GD units (5% vs 7%), with or without adjustment for GA. The 
frequency and duration of intubated ventilation were less in GD units (43% vs 51% and 2 vs 
6 days, respectively; both P < .001), but the significances disappeared after GA adjustment. 
The median age for introduction of enteral feeding was older in GD vs non-GD units (3 vs 2 
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days; P < .001), both with and without GA adjustment. TFF120 and TFF150 were 26 and 34 
days, respectively, compared with 11 and 15 days for the non-GD units (both P < .001; Table 
2). Figure 2 shows TFF120 in relation to postnatal days for all units, and the median TFF120 
and TFF150 were 8–33 and 11–47 days, respectively (Table 2). In Figure 3, TFF120 for the 
individual units are depicted together with 4 key clinical outcomes adjusted for the 
differences in GA among infants (mortality, growth rate, NEC incidence, antibiotics use). 
PN was administered for a longer time in GD vs non-GD units, with or without GA 
adjustment (25 vs 13 days; P < .001; Table 2). Growth velocity for weight was 5.0–14.6 
g/kg/d (0–28 days) and ∆z-scores −0.54 to −1.64, and both variables were lower in GD vs 
non-GD hospitals (8.7 vs 10.9 g/kg/d and −1.23 vs −0.91, respectively), with or without GA 
adjustment (Table 2). Growth velocity and z-score change for length did not differ between 
GD and non-GD units. The z-score for head circumference decreased less in GD vs non-GD 
units, but the difference disappeared after GA adjustment (Table 2). 
Antibiotics were used more in GD units compared with non-GD units (99% vs 92% and 17 vs 
11 days; both P < .001; Table 2). The incidence of NEC varied widely among hospitals (1%–
13%; Table 2), with the mean day and PCA at onset being 8–27 days and 28.4–33.6 weeks, 
respectively. NEC rates tended to be lower in GD vs non-GD hospitals (4% vs 6%; P = .009), 
with fewer severe NEC cases (Bell score II/III, 39/9 vs 47/33; P = .007), earlier age at onset 
(13 vs 21 days; P < .001), and fewer NEC surgeries (16% vs 42%; P = .001). However, these 
differences became insignificant when adjusted for GA (P2-values in Table 2). The first stool 
was passed earlier in GD units with or without adjustment for GA (2 vs 3 days in non-GD 
units; P < .001). 
There was considerable heterogeneity in demographic and outcome data among the 8 non-
GD units that practiced early and fast progression of human milk feeding (Figure 1, Tables 1 
and 2). Particularly, Ibadan (n = 150, Africa) tended to differ from the others (n = 1431 from 
mainly Western countries) with a higher mortality rate (18% vs 6 %), GA (30.5 vs 28.8 
weeks), and BW (1223 vs 1072 g); more SGA infants (27% vs 18%); and fewer singletons 
(55% vs 71%), caesarean deliveries (44% vs 64%), antenatal steroid treatments (31% vs 
89%), infants provided intubated respiratory support (4% vs 56%), and parenteral amino 
acids (51% vs 94%; all P < .01; Tables 1 and 2). 
 
<H1>Discussion</H1> 
Our study demonstrates marked differences in nutrition practices and short-term clinical 
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outcomes for hospitalized VLBW infants around the world. Specifically, the predominant use 
of formula, and a long TFF for the 5 NICUs in South China, was associated with more use of 
antibiotics and less weight gain during the first 4 weeks of life, but this apparently did not 
affect the in-hospital NEC or mortality rates, compared with the remaining units. Although 
the TFF depends on the infant’s clinical conditions, the significant variability among NICUs 
demonstrates that many other factors contribute to the chosen nutrition practice. These 
include availability of human milk and PN, physical infrastructure of NICUs, clinical and 
cultural traditions, and the perception of doctors and nurses toward signs of feeding 
intolerance and NEC. Thus, a combination of infant- and hospital-related factors determines 
the time to full enteral feeding in NICUs (Figure 4). It remains important to investigate 
whether these differences for in-hospital feeding regimens and short-term clinical outcomes 
have long-term effects on infant health and development. 
The more conservative approach to volume advancement in South China resulted in a TFF 
that was more than twice of that in other hospitals. Although longer PN was used to 
compensate for slow enteral feeding advancement, a reduced weight gain was observed in 
GD units, reflecting the difficulties in achieving adequate growth during the first 4 weeks 
using mainly PN. Importantly, this was associated with 50% more days receiving antibiotics, 
probably because of an increased risk for infections from indwelling catheters for PN or 
differences in clinical guidelines. Differences in use of antenatal steroids and respiratory 
support might also have influenced both TFF and NEC rates. Unknown confounders, such as 
hospital-specific gut colonization, genetics, differences in diagnostic criteria (Bell scoring), 
and access to surgery for NEC may also contribute to differences among units. Further, we 
did not know the NEC incidence for infants discharged early to step-down units or to home 
after parental request. Consequently, the differences in NEC incidences must be interpreted 
with caution. 
Formula feeding has been associated with a higher risk for feeding interruption because of 
emesis, abdominal distension, bloody stools, or suspicion of NEC,
27
 and increased NEC 
rates.
28
 Consequently, predominant use of formula feeding may have contributed to the more 
conservative enteral feeding in the GD units. Moreover, clinical features of feeding 
intolerance, used as early signs of NEC, are nonspecific and vary widely among units and 
clinicians. This may lead to unjustified delay in enteral feeding, regardless of diet.
29
 More 
research is required to evaluate and predict the clinical consequences of the variable 
symptoms of feeding intolerance. Nevertheless, it may be important to alter feeding 
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advancement rate and criteria for withholding feeding according to the availability of human 
milk. However, our data cannot be used to provide direct evidence to support specific diet 
and feeding regimens, because this would require large randomized clinical trials (RCTs). 
The advantages of MM for preterm infants are well-known, leading health authorities around 
the world to strongly recommend the use of MM for VLBW infants.
16,30
 Unfortunately, not 
all mothers can provide their infants with sufficient amounts of MM, especially when 
initiation of lactation is delayed after preterm birth.
31,32
 It is difficult to increase the 
availability of human milk if the hospital infrastructure does not allow cohospitalization of 
mothers, lactation support, or DM banking. The African NICU (Ibadan) had a relatively high 
mortality rate, despite early feeding with MM, which may be related to sepsis
22
 and more 
limited use of some clinical treatments (eg, respiratory and PN support). The presence of 
human milk banks may positively influence breast-feeding rates for preterm infants, and 
several feeding guidelines propose to use DM when MM is not available or insufficient.
33,34
 
The number of countries with DM banks has increased,
35,36
 and in the 3 non-GD units with 
access to DM, TFF120 was reached already after 8–11 days. At 2 of these units, enteral 
feeding started on the first day after birth, compared with days 2–4 in units without access to 
DM. Delaying feeding introduction until MM becomes available is common (rather than 
starting on IF), especially for the smallest infants, but limited scientific evidence is 
available.14,17 Delayed start of enteral feeding often reflects a concern for NEC, but there is 
also a risk that enteral fasting after birth will delay intestinal maturation, induce mucosal 
atrophy, and reduce the digestive capacity.
4
 In a recent randomized trial, there was no 
difference in NEC and sepsis rates between preterm infants who received DM or IF as 
supplement to MM for the first 10 days after birth.20 Intestinal maturation may not be optimal 
unless the mother’s own colostrum is given as the first feed.37 Interestingly, bovine 
colostrum, given as a supplement to MM during the first 14 days, reduced TFF in 2 GD units 
in a recent pilot trial.38 
Our study has several strengths and limitations. A major strength is the wide geographic 
variation in the participating NICUs with a large number of infants, which enabled a 
comparison of nutrition practices across several continents. Limitations include that the 
design was primarily retrospective, with some missing data and potentially important 
unmeasured confounders. Clinical outcomes (eg, NEC, mortality) were unclear for infants 
subjected to early discharge on parental request in GD units and discharged to step-down 
units in European units. In some GD units, parents asked for early discharge if their infant 
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was stable before reaching the required body weight for discharge (ie, 2000 g). Other reasons 
for discharge on parental request may include economic or social limitations, leading to 
giving up further treatments or transferring to another hospital near home. Finally, it is 
important to note that participating NICUs in this study may not be representative of those in 
their respective countries or continents, and clinical routines may be changing rapidly in 
newly urbanized regions, like South China. Different hospital settings and infant 
demographics and genetics may have a different balance of risks and benefits for selected 
treatments. Thus, trials performed in 1 hospital or region cannot always be translated to other 
settings. 
In summary, nutrition practices and clinical outcomes varied markedly among NICUs 
worldwide. Much longer time to full enteral feeding, more use of formula feeding and 
antibiotics, prolonged use of PN, and lower weight gain were observed in NICUs in the GD 
region in South China, but this did not appear to be associated with increased risk for in-
hospital NEC or death. It may be important to vary nutrition strategies (eg, advancement rate, 
criteria for withholding feeding) according to different NICU settings (eg, availability of 
human milk and PN, access to surgery for NEC). Large RCTs are required to identify the 
optimal nutrition strategies for VLBW preterm infants, and our data provide valuable 
information for planning such trials. The results have contributed to the design of an ongoing 
large randomized trial comparing supplemental bovine colostrum with IF during the first 14 
days on TFF in some GD hospitals (ClinicalTrials.gov identifier: NCT03085277). It is also 
relevant, based on the present observational results, to investigate in RCTs how slow vs fast 
feeding advancement rate, different feeding intolerance assessments, and time and duration of 
antibiotics use may affect clinical outcomes, especially in hospitals with limited access to 
human milk. However, clinical routines for VLBW infants are changing rapidly (eg, use of 
human milk and antibiotics), both in China and in many other areas of the world. Thus, it 
may soon become relevant in follow-up observational studies to compare the present data 
from the NEOMUNE-NeoNutriNet database with updated data on clinical routines and 
outcomes for VLBW infants. 
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Figure 1. Type of enteral nutrition 0–28 days after birth in 13 neonatal intensive care units 
(NICUs) around the world. AMS, Academic Medical Center; AUC, University of Auckland 
and Newborn Service, National Women’s Health; BWC, Shenzhen Bao’an Maternal and 
Child Health Hospital; CHI, Rush University Children’s Hospital; COP, University of 
Copenhagen; FOS, Foshan Woman and Children’s Hospital; IBA, University of Ibadan and 
University College Hospital; IF, exclusive infant formula; MM, exclusively own mother’s 
milk; MM+DM, own mother’s milk and/or donor milk; mixed, MM+DM and IF; missing, 
missing values due to lack of data, infant death, or discharge; NEW, Newcastle Hospitals 
NHS Foundation Trust; NPO, nil per os; PER, University of Western Australia and King 
Edward Memorial Hospital; PWC, Guangdong Provincial Women & Children’s Hospital; 
SNP, Shenzhen Nanshan People’s Hospital; SWC, Shenzhen Maternity & Child Health Care 
Hospital; TAI, Children’s Hospital of China Medical University. 
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Figure 2. Proportion of infants reaching enteral feeding volumes of 120 mL/kg/d relative to 
infant age in South China units (GD) and other units (non-GD) around the world. AMS, 
Academic Medical Center; AUC, University of Auckland and Newborn Service, National 
Women’s Health; BWC, Shenzhen Bao’an Maternal and Child Health Hospital; CHI, Rush 
University Children’s Hospital; COP, University of Copenhagen; FOS, Foshan Woman and 
Children’s Hospital; GD, Guangdong province in China; IBA, University of Ibadan and 
University College Hospital; PER, University of Western Australia and King Edward 
Memorial Hospital; PWC, Guangdong Provincial Women & Children’s Hospital; SNP, 
Shenzhen Nanshan People’s Hospital; SWC, Shenzhen Maternity & Child Health Care 
Hospital; TAI, Children’s Hospital of China Medical University. 
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Figure 3. Association between time to full feeding (median days to 120 mL/kg/d) and 
gestation age–corrected mortality (A), weight ∆z-scores at 0–28 days (B), necrotizing 
enterocolitis incidence (C), and days receiving antibiotics (D) in South China (Guangdong) 
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hospitals (gray symbols) and other hospitals around the world (black symbols). AMS, 
Academic Medical Center; AUC, University of Auckland and Newborn Service, National 
Women’s Health; BWC, Shenzhen Bao’an Maternal and Child Health Hospital; CHI, Rush 
University Children’s Hospital; COP, University of Copenhagen; FOS, Foshan Woman and 
Children’s Hospital; IBA, University of Ibadan and University College Hospital; NEW, 
Newcastle Hospitals NHS Foundation Trust; PER, University of Western Australia and King 
Edward Memorial Hospital; PWC, Guangdong Provincial Women & Children’s Hospital; 
SNP, Shenzhen Nanshan People’s Hospital; SWC, Shenzhen Maternity & Child Health Care 
Hospital; TAI, Children’s Hospital of China Medical University; TFF120, time to reach 
enteral feeding volumes of 120 mL/kg/day. 
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Figure 4. Many different factors influence the time taken to reach full enteral feeding in 
preterm infants. These factors are related to the infants, but also to the parents, clinical staff, 
and hospital conditions. 
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Table 1. Demographic Characteristics at Birth and Use of Antenatal Steroids, Milk 
Fortification, and Probiotics in South China NICUs (GD) and in Other Units Around the 
World (Non-GD). 
Hospital FOS SWC SNP BWC PWC AUC CHI COP AMS NEW PER TAI IBA GD 
Non-
GD 
Total 
included 
407 458 93 167 241 160 177 284 270 139 152 249 150 1366 1581 
Gestational 
age, weeks 
30.4 
(2.1) 
30.3 
(2.2) 
30.4 
(2.0) 
29.7 
(2.0) 
30.5 
(2.1) 
29.0 
(2.7) 
28.3 
(2.5) 
28.0 
(2.5) 
28.6 
(2.2) 
28.4 
(2.8) 
29.4 
(2.5) 
29.9 
(2.6) 
30.5 
(2.4) 
30.3 
(2.1) 
29.0 
(2.6)
a
 
Birth 
weight 
               
 g 
1237 
(184) 
1254 
(177) 
1245 
(219) 
1250 
(183) 
1262 
(172) 
1101 
(262) 
1025 
(252) 
990 
(267) 
1070 
(258) 
1043 
(280) 
1127 
(257) 
1165 
(236) 
1223 
(191) 
1250 
(182) 
1086 
(262)
a
 
 z-Score 
−0.5
6 
(0.99
) 
−0.44 
(1.06
) 
−0.66 
(0.90
) 
−0.20 
(0.84
) 
−0.55 
(1.05
) 
−0.32 
(1.03
) 
−0.25 
(0.94
) 
−0.31 
(0.93
) 
−0.24 
(0.95
) 
−0.34 
(0.92
) 
−0.45 
(0.9) 
−0.56 
(1.05
) 
−0.62 
(1.24
) 
−0.48 
(1.01
) 
−0.38 
(1.00
) 
Birth length                
 cm 
38 
(4) 
39 
(4) 
38 
(3) 
39 
(3) 
38 
(3) 
37 
(4) 
36 
(3) 
36 
(4) 
36 
(3) 
UNK 
37 
(4) 
38 
(3) 
38 
(3) 
39 
(3) 
37 
(4)
a
 
 z-Score 
−0.4
3 
(1.48
) 
−0.02 
(1.59
) 
−0.64 
(1.18
) 
0.06 
(1.04
) 
−0.57 
(1.45
) 
−0.12 
(1.24
) 
−0.31 
(1.08
) 
−0.2 
(1.12
) 
−0.43 
(1.18
) 
UNK 
−0.23 
(1.14
) 
−0.32 
(1.30
) 
−0.51 
(1.30
) 
−0.27 
(1.47
) 
−0.30 
(1.20
) 
Birth head 
circumferen
ce 
               
 cm 
26.7 
(1.9) 
27.1 
(2.2) 
27.3 
(1.8) 
27.0 
(1.7) 
27.3 
(1.8) 
26.3 
(2.1) 
25.1 
(2.1) 
25.3 
(2.7) 
25.9 
(2.4) 
25.6 
(1.9) 
26.2 
(2.4) 
26.3 
(2.1) 
27.3 
(1.8) 
27.0 
(2.0) 
26.0 
(2.3)
a
 
 z-Score −0.6 −0.27 −0.33 −0.02 −0.27 0.05 −0.33 −0.11 −0.02 −0.14 −0.29 −0.50 −0.21 −0.36 −0.20 
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3 
(1.41
) 
(1.62
) 
(1.16
) 
(1.08
) 
(1.36
) 
(1.06
) 
(1.11
) 
(0.98
) 
(1.08
) 
(1.06
) 
(1.12
) 
(1.23
) 
(1.34
) 
(1.44
) 
(1.14
) 
Small for 
gestational 
age, n (%) 
84 
(21) 
86 
(19) 
24 
(26) 
19 
(11) 
52 
(22) 
27 
(17) 
28 
(16) 
49 
(17) 
40 
(15) 
24 
(17) 
28 
(18) 
61 
(24) 
40 
(27) 
265 
(19) 
297 
(19) 
Male, n 
(%) 
230 
(57) 
231 
(51) 
43 
(46) 
108 
(65) 
153 
(63) 
80 
(50) 
95 
(54) 
130 
(46) 
135 
(50) 
71 
(51) 
72 
(47) 
116 
(47) 
66 
(44) 
765 
(56) 
765 
(48)
a
 
Singleton, 
n (%) 
278 
(69) 
270 
(59) 
72 
(78) 
124 
(74) 
164 
(68) 
115 
(72) 
151 
(85) 
165 
(58) 
204 
(76) 
29 
(73) 
116 
(76) 
170 
(68) 
82 
(55) 
908 
(67) 
1032 
(70) 
Caesarean 
section, n 
(%) 
251 
(62) 
312 
(68) 
62 
(67) 
65 
(39) 
142 
(59) 
104 
(65) 
117 
(66) 
193 
(68) 
154 
(57) 
71 
(52) 
99 
(65) 
178 
(71) 
66 
(44) 
832 
(61) 
982 
(62) 
Steroids                
 Any 
steroids, n 
(%) 
155 
(38) 
106 
(70) 
74 
(80) 
85 
(52) 
92 
(38) 
157 
(98) 
164 
(93) 
203 
(88) 
235 
(87) 
131 
(94) 
141 
(93) 
193 
(78) 
47 
(31) 
512 
(49) 
1271 
(83)
a
 
 
Complete 
steroids, n 
(%) 
82 
(20) 
75 
(50) 
52 
(57) 
37 
(22) 
65 
(27) 
119 
(74) 
124 
(70) 
170 
(73) 
154 
(57) 
97 
(70) 
118 
(78) 
155 
(62) 
28 
(19) 
311 
(30) 
965 
(63)
a
 
Human 
milk 
fortifier 
               
 n (%) 0 (0) 
167 
(37) 
22 
(24) 
0 (0) 8 (3) 
138 
(86) 
135 
(76) 
163 
(57) 
187 
(69) 
UNK
b
 
140 
(92) 
197 
(79) 
0 (0) 
197 
(14) 
960 
(67)
a
 
 Day of 
life  
— 
24 
(8) 
23 
(8) 
— 
22 
(8) 
10 
(7) 
20 
(9) 
21 
(9) 
12 
(5) 
UNK
b
 
11 
(5) 
15 
(9) 
— 
24 
(8) 
15 
(8)
a
 
Probiotics, 
n (%) 
67 
(17) 
38 
(11) 
0 (0) 
79 
(47) 
78 
(33) 
106 
(67) 
0 (0) 
227 
(81) 
0 (0) 
34 
(81) 
109 
(72) 
43 
(17) 
0 (0) 
262 
(21) 
515 
(35)
a
 
Observation 35 40 32 42 37 38 58 46 30 45 46 49 23 38 42 
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period,
c
 
days  
(18) (17) (16) (18) (18) (26) (20) (27) (23) (28) (22) (18) (12) (18) (25)
a
 
Data are presented as mean (SD) unless otherwise stated. 
AMS, Academic Medical Center; AUC, University of Auckland and Newborn Service, 
National Women’s Health; BWC, Shenzhen Bao’an Maternal and Child Health Hospital; 
CHI, Rush University Children’s Hospital; COP, University of Copenhagen; FOS, Foshan 
Woman and Children’s Hospital; GD, Guangdong province in China; IBA, University of 
Ibadan and University College Hospital; NEW, Newcastle Hospitals NHS Foundation Trust; 
PER, University of Western Australia and King Edward Memorial Hospital; PWC, 
Guangdong Provincial Women & Children’s Hospital; SNP, Shenzhen Nanshan People’s 
Hospital; SWC, Shenzhen Maternity & Child Health Care Hospital; TAI, Children’s Hospital 
of China Medical University; UNK, unknown. 
a
Significant difference between CN and non-CN (P < .001). 
b
Human milk fortifier was used, but exact data are missing. 
c
Data were collected from <24 hours after birth to postconceptional age 37 weeks, or less if 
infants were transferred to a different (step-down) unit, discharged to home (including 
discharge on parental request), or died. 
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Table 2. Anthropometric and Clinical Outcomes in South China (GD) NICUs and Other 
NICUs Around the World (Non-GD). 
Hospital FOS SWC SNP BWC PWC AUC CHI COP AMS NEW PER TAI IBA 
GD Non-
GD 
P1 P2 
Mortality (%) 
42 
(10) 
7 (2) 3 (3) 14 (8) 7 (3) 2 (1) 1 (1) 
38 
(13) 
29 
(11) 
7 (5) 6 (4) UNK 
27 
(18) 
73 (5) 110 
(7) 
NS NS 
Intubation 
ventilation 
             
    
 n (%) 
182 
(46) 
131 
(30) 
26 
(28) 
 
98 
(59) 
145 
(60) 
84 
(53) 
141 
(80) 
144 
(51) 
170 
(63) 
90 
(65) 
85 
(56) 
78 
(32) 
6 (4) 
582 
(43) 
798 
(51)
a
 
—
a
 NS 
 Days
b
 3 (7) 1 (3) 2 (3) 4 (6) 3 (5) 5 (10) 
11 
(16) 
5 (11) 8 (14) 8 (13) 3 (9) 4 (11) 0 (0) 
2 (5) 6 
(12)
a
 
—a NS 
Start enteral 
nutrition 
                 
 n (%) 
371 
(92) 
441 
(97) 
83 
(89) 
165 
(99) 
227 
(94) 
156 
(99) 
177 
(100) 
282 
(99) 
268 
(100) 
137 
(99) 
149 
(99) 
249 
(100) 
144 
(96) 
1287 
(95) 
1562 
(99) 
—a —a 
 DOL, median 
(IQR) 
4 (2–
6) 
2 (2–
3) 
3 (3–
6) 
2 (2–
3) 
3 (1–
6) 
2 (1–
2) 
3 (3–
5) 
1 (1–
2) 
1 (1–
1) 
4 (2–
5) 
2 (2–
3) 
2 (2–
4) 
3 (3–
5) 
3 (2–
5) 
2 (1–
3) 
—a  —a  
TFF (120 
mL/kg/d) 
                 
 n (%) 
233 
(58) 
392 
(86) 
58 
(62) 
126 
(75) 
160 
(66) 
141 
(88) 
176 
(99) 
235 
(83) 
204 
(76) 
UNK 
146 
(96) 
245 
(98) 
119 
(79) 
969 
(71) 
1266 
(88) 
—a —a  
 DOL, median 
(IQR) 
33 
(23–
45) 
24 
(20–
29) 
26 
(19–
37) 
26 
(17–
38) 
27 
(20–
41) 
11 
(9–
14) 
15 
(12–
22) 
12 
(8–
16) 
11 
(9–
15) 
UNK 
8 (7–
11) 
12 
(9–
17) 
11 
(8–
14) 
26 
(20–
37) 
11 
(9–
16) 
—a —a 
TFF (150 
mL/kg/d) 
                 
 n (%) 
155 
(38) 
373 
(82) 
41 
(44) 
90 
(54) 
124 
(51) 
138 
(86) 
171 
(97) 
222 
(78) 
173 
(64) 
117 
(85) 
144 
(95) 
166 
(67) 
110 
(73) 
783 
(58) 
1241 
(79) 
—a —a 
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 DOL, median 
(IQR) 
47 
(30–
60) 
30 
(24–
36) 
38 
(25–
49) 
37 
(26–
61) 
37 
(28–
50) 
12 
(10–
16) 
19 
(14–
28) 
14 
(10–
20) 
15 
(12–
22) 
13 
(10–
17) 
11 
(8–
16) 
35 
(20–
68) 
13 
(11–
18) 
34 
(26–
49) 
15 
(11–
25) 
—a —a 
Parenteral amino 
acids 
                 
 n (%) 
389 
(96) 
455 
(100) 
92 
(99) 
167 
(100) 
233 
(97) 
154 
(96) 
176 
(99) 
231 
(81) 
269 
(100) 
131 
(94) 
148 
(97) 
236 
(95) 
76 
(51) 
1336 
(98) 
1421 
(90) 
—a —a 
 Days
b
 
27 
(15) 
24 
(10) 
25 
(12) 
28 
(13) 
24 
(15) 
15 
(11) 
22 
(15) 
11 (9) 
15 
(11) 
14 
(14) 
11 (7) 11 (7) 3 (5) 
25 
(13) 
13 
(11) 
—
a
 —
a
 
Parenteral lipids                  
 n (%) 
293 
(72) 
453 
(99) 
90 
(97) 
159 
(95) 
185 
(77) 
151 
(94) 
176 
(99) 
221 
(78) 
269 
(100) 
131 
(94) 
145 
(95) 
80 
(32) 
0 (0) 
1180 
(86) 
1173 
(74) 
—a —a 
 Days
b 
18 
(16) 
20 
(10) 
24 
(12) 
21 
(12) 
16 
(14) 
13 
(11) 
22 
(15) 
9 (8) 
14 
(11) 
14 
(14) 
9 (7) 4 (7) 0 
19 
(13) 
11 
(12) 
—
a
 —
a
 
Weight GV                  
 g/kg/d
c
 
8.7 
(4.1) 
9.3 
(2.3) 
12.7 
(3.1) 
10.5 
(3.4) 
5.0 
(3.5) 
14.6 
(4.1) 
12.1 
(3.8) 
11.2 
(3.8) 
11.0 
(4.6) 
10.0 
(4.4) 
12.6 
(4.0) 
8.0 
(4.3) 
8.8 
(5.7) 
8.7 
(4.2) 
10.9 
(4.6) 
—a —a 
 ∆z-Scored 
−1.24 
(0.48) 
−1.18 
(0.31) 
−0.62 
(0.38) 
−1.04 
(0.41) 
−1.64 
(0.42) 
−0.54 
(0.49) 
−0.83 
(0.51) 
−0.86 
(0.48) 
−0.83 
(0.50) 
−0.88 
(0.45) 
−0.73 
(0.41) 
−1.25 
(0.42) 
−1.30 
(0.67) 
−1.23 
(0.50) 
−0.91 
(0.53) 
—a —a 
Length GV                  
 cm/week
c
 
0.8 
(0.6) 
1.0 
(0.6) 
0.9 
(0.6) 
0.9 
(0.4) 
UNK 
1.0 
(0.5) 
0.8 
(0.5) 
0.9 
(0.5) 
0.7 
(0.5) 
UNK 
1.2 
(0.5) 
0.7 
(0.5) 
0.0 
(0.0) 
0.9 
(0.5) 
0.8 
(0.5) 
NS NS 
 ∆z-Scored 
−0.96 
(1.12) 
−0.52 
(0.95) 
−0.52 
(0.89) 
−0.80 
(0.59) 
UNK 
−0.54 
(0.83) 
−0.86 
(0.76) 
−0.74 
(0.84) 
−1.04 
(0.86) 
UNK 
−0.22 
(0.74) 
−1.08 
(0.85) 
−2.46 
(0.2) 
−0.77 
(0.90) 
−0.92 
(0.85) 
NS NS 
Head 
circumference 
GV 
                 
 cm/week
c
 
0.5 
(0.4) 
0.7 
(0.3) 
0.6 
(0.3) 
0.5 
(0.3) 
UNK 
0.5 
(0.3) 
0.5 
(0.3) 
0.7 
(0.3) 
0.5 
(0.3) 
UNK 
0.6 
(0.3) 
0.3 
(0.3) 
0.6 
(0.4) 
0.5 
(0.3) 
0.5 
(0.3) 
NS NS 
 ∆z-Scored 
−1.19 
(1.32) 
−0.43 
(0.92) 
−0.72 
(0.79) 
−1.18 
(0.81) 
UNK 
−1.32 
(0.90) 
−1.18 
(0.85) 
−0.73 
(0.93) 
−1.09 
(0.77) 
UNK 
−0.75 
(1.07) 
−1.81 
(1.10) 
−0.96 
(1.26) 
−0.97 
(1.03) 
−1.29 
(1.05) 
—a NS 
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Data are presented as mean (SD) unless otherwise stated. 
AMS, Academic Medical Center; AUC, University of Auckland and Newborn Service, 
National Women’s Health; BWC, Shenzhen Bao’an Maternal and Child Health Hospital; 
CHI, Rush University Children’s Hospital; COP, University of Copenhagen; DOL, day of 
life; FOS, Foshan Woman and Children’s Hospital; GD, Guangdong province in China; GV, 
growth velocity; IBA, University of Ibadan and University College Hospital; ND, not done; 
NEC                  
 n (%) 8 (2) 5 (1) 5 (5) 6 (4) 
25 
(10) 
5 (3) 10 (6) 20 (7) 
32 
(12) 
18 
(13) 
1 (1) 2 (1) 2 (1) 
49 (4) 90 (6) NS NS 
 NEC scores, 
Bell II/III 
7/0 4/0 5/0 2/4 20/5 3/2 UNK 8/12 26/6 6/12 0/1 2/0 2/0 
39/9 47/33 NS NS 
 Day of NEC 
onset 
12 (9) 11 (8) 
11 
(12) 
15 (9) 
14 
(11) 
27 
(18) 
25 (9) 
18 
(16) 
23 
(16) 
17 
(15) 
13 (–) 
20 
(10) 
8 (1) 
13 
(10) 
21 
(15) 
—
a
 NS 
  
Postconceptional 
age at NEC 
onset 
225 
(20) 
214 
(12) 
215 
(15) 
228 
(15) 
221 
(13) 
203 
(28) 
215 
(14) 
202 
(17) 
217 
(15) 
199 
(15) 
221 
(–) 
226 
(6) 
235 
(7) 
221 
(16) 
210 
(18) 
—
a
 NS 
 Surgery for 
NEC, n (%) 
0 (0) 0 (0) 0 (0) 3 (43) 5 (20) 3 (60) 5 (50) 
10 
(50) 
8 (25) 
11 
(61) 
1 
(100) 
0 (0) 0 (0) 
8 (16) 38 
(42) 
NS NS 
First stool, DOL 2 (1) 2 (1) 1 (0) 2 (1) 2 (1) 3 (2) UNK 4 (3) 3 (1) UNK 3 (2) 1 (1) 2 (1) 2 (1) 3 (2) —a —a 
Antibiotics                  
 n (%) 
399 
(99) 
456 
(100) 
93 
(100) 
165 
(99) 
235 
(98) 
149 
(93) 
174 
(98) 
233 
(82) 
256 
(95) 
125 
(90) 
143 
(94) 
233 
(94) 
147 
(98) 
1348 
(99) 
1460 
(92) 
—a —a 
 Days
b
 
19 
(12) 
12 
(10) 
25 
(13) 
23 
(13) 
16 
(10) 
11 
(12) 
13 
(12) 
12 
(11) 
13 
(12) 
8 (9) 7 (7) 8 (8) 16 (9) 
17 
(12) 
11 
(11) 
—a —a 
Antifungal 
medicine 
             
    
 n (%) 
59 
(15) 
109 
(24) 
12 
(13) 
65 
(39) 
29 
(14) 
148 
(93) 
76 
(43)
e
 
9 (3) 
28 
(10) 
34 
(81) 
112 
(74) 
18 (7) 
35 
(24) 
274 
(21) 
384 
(29) 
—a NS 
 Days
b 
1 (3) 2 (4) 1 (4) 2 (4) 1 (5) 
15 
(14) 
UNK 
17 
(16) 
1 (4) 
12 
(19) 
22 
(26) 
3 (10) 3 (9) 
1 (4) 8 (16) —a ND 
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NEC, necrotizing enterocolitis; NEW, Newcastle Hospitals NHS Foundation Trust; NICU, 
neonatal intensive care unit; NS, nonsignificant; PER, University of Western Australia and 
King Edward Memorial Hospital; PWC, Guangdong Provincial Women & Children’s 
Hospital; SNP, Shenzhen Nanshan People’s Hospital; SWC, Shenzhen Maternity & Child 
Health Care Hospital; TAI, Children’s Hospital of China Medical University; TFF, time to 
full feeding; UNK, unknown. 
a
Significant differences between GD and non-GD, P < .001; P1, unadjusted P-value 
comparing GD and non-GD units; P2, P-value comparing GD and non-GD units, adjusted for 
gestational age. 
b
Deceased infants were excluded from analysis. 
c
 
d
Days 0–28. 
e
All infants with body weight <1000 g received prophylactic fluconazole from birth until the 
central line was removed. 
